Caps cost-sharing for prescription insulin drugs at $25 per prescription.

This bill mandates that policies, contracts, or plans providing third-party payment or prepayment of health or medical expenses cap the total amount of cost-sharing for prescription insulin drugs at $25 per prescription for up to a 31-day supply. The cap applies to rapid-acting, short-acting, intermediate-acting, and long-acting insulin drugs. The bill does not affect other types of specialized health-related insurance. The commissioner of insurance can adopt rules to administer these requirements.

Caps cost-sharing for prescription insulin drugs at $25 per prescription.

This bill mandates that policies, contracts, or plans providing third-party payment or prepayment of health or medical expenses cap the total amount of cost-sharing for prescription insulin drugs at $25 per prescription for up to a 31-day supply. The cap applies to rapid-acting, short-acting, intermediate-acting, and long-acting insulin drugs. The bill does not affect other types of specialized health-related insurance. The commissioner of insurance can adopt rules to administer these requirements.